Developing a new national MDMA policy:Results of a multi-decision multi-criterion decision analysis

Autor: Jan van Amsterdam, Cees Maris, Raoul Pieter Joost Koning, Johannes G. Ramaekers, Gjalt-Jorn Peters, Ton Nabben, E.J.M. Pennings, Kaj Hollemans, Wim van den Brink, Floor van Bakkum, J J Breeksema, Tjibbe Reitsma, Tom Blickman, Willem Scholten, Judith Noijen

Publikováno v: Amsterdam, J V, Peters, G-J Y, Pennings, E, Blickman, T, Hollemans, K, Breeksema, J J J, Ramaekers, J G, Maris, C, Bakkum, F V, Nabben, T, Scholten, W, Reitsma, T, Noijen, J, Koning, R & Brink, W V D 2021, ' Developing a new national MDMA policy : Results of a multi-decision multi-criterion decision analysis ', Journal of Psychopharmacology, vol. 35, no. 5, 0269881120981380, pp. 537-546 . https://doi.org/10.1177/0269881120981380
Journal of Psychopharmacology, 35(5):0269881120981380, 537-546. SAGE Publications Ltd
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Inc.
Journal of psychopharmacology (Oxford, England), 35(5), 537-546. SAGE Publications Ltd
Journal of Psychopharmacology (Oxford, England)
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Ltd

Background: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dependence liability but is scheduled on List I of the Dutch Opium Act (‘hard drugs’). Concerns surrounding increasing MDMA-related criminality coupl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76cf60f794eb5e34ad60b2743bb588d9
https://research.ou.nl/en/publications/5f18fe67-c218-4525-91f0-ee464bc8c268